Literature DB >> 17763835

Intratympanic application of botulinum toxin: experiments in guinea pigs for excluding ototoxic effects.

Thorsten Zehlicke1, Christoph Punke, Dirk Dressler, Hans Wilhelm Pau.   

Abstract

The aim of the study was to exclude ototoxic side effects of intratympanally applied botulinum toxin. The background is that a transection of the tensor tympani tendon (tenotomy) may relieve symptoms of tinnitus due to myoclonic tensor contractions. Moreover, there are certain indications that in some cases tenotomy may influence the course of Menière's disease positively. In such cases, a temporary (probatory) inactivation of the muscle with botulinum toxin might be better than a definitive surgical solution. Although in theory botulinum toxin should not have ototoxic side effects, a study on animals (guinea pigs) should prove this assumption. On eight guinea pigs (16 ears), the middle ear spaces (bullae) were opened and botulinum toxin was introduced. Hearing thresholds were measured via ABR recordings, prior to 1 and 3 weeks, respectively, after botulinum toxin application. Histological examinations of the middle ear mucosa were performed on each animal. In our series, the hearing thresholds remained essentially unchanged. Furthermore, no middle ear pathologies could be found in histology. No negative effects of botulinum toxin on hearing could be observed in our series. This is a precondition for the further development of the concept of intratympanical applications of the drug, to inactivate the tensor tympani muscle or for other options.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17763835     DOI: 10.1007/s00405-007-0432-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

1.  Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs.

Authors:  S Rohrbach; A Olthoff; R Laskawi; B Giefer; W Götz
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-11       Impact factor: 1.547

Review 2.  Therapeutic uses of botulinum toxin.

Authors:  J Jankovic; M F Brin
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

3.  [Myoclonus].

Authors:  B Schwab; T Lenarz
Journal:  HNO       Date:  1998-10       Impact factor: 1.284

4.  Control of Frey's syndrome in patients treated with botulinum toxin type A.

Authors:  Kuauhyama Luna Ortiz; Mario Rascon Ortiz; Jesús A Sansón Riofrio; Verónica Villavicencio Valencia; Adalberto Mosqueda Taylor
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2007-01-01

Review 5.  [Treatment of laryngeal movement disorders with botulinum toxins: part 1: History and mode of action].

Authors:  C Schwemmle; M Ptok
Journal:  HNO       Date:  2007-05       Impact factor: 1.284

6.  Objective Tinnitus and the Tensor Tympani Muscle.

Authors: 
Journal:  Int Tinnitus J       Date:  1995

7.  Evaluation of botulinum toxin A in treatment of tinnitus.

Authors:  Katrina R Stidham; Perry H Solomon; Joseph B Roberson
Journal:  Otolaryngol Head Neck Surg       Date:  2005-06       Impact factor: 3.497

8.  Management of middle ear myoclonus.

Authors:  L Badia; A Parikh; G B Brookes
Journal:  J Laryngol Otol       Date:  1994-05       Impact factor: 1.469

9.  Objective high-frequency tinnitus of middle-ear myoclonus.

Authors:  Khader J Abdul-Baqi
Journal:  J Laryngol Otol       Date:  2004-03       Impact factor: 1.469

Review 10.  The role of botulinum toxin in the management of head and neck cancer patients.

Authors:  Rainer Laskawi; Maik Ellies
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2007-04       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.